Characterization of opiate binding sites on the goldfish (Carassius auratus L.) pronephric leukocytes

Polish Journal of Pharmacology

Volumn 49, Issue 4, 1997, Pages 229-237

  Józefowski, Szczepan ^a   Płytycz, Barbara ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cyprodime; Fish; Leukocyte; Naloxone; Naltrexone; Naltrindole; Nor binaltorphimine; Opioid receptor

Indexed keywords

CYPRODIME; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GOLDFISH; KIDNEY; LEUKOCYTE; NONHUMAN; RECEPTOR DENSITY;

ANIMALS; BINDING SITES; GOLDFISH; LEUKOCYTES; MORPHINANS; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 1842407154     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Ader R., Felten D., Cohen N.: Interaction between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol., 1990, 30, 561-602.
2. Appel N., Kiritsy-Roy J. A., Van Loon G. R.: Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increase in central sympathetic outflow. Brain Res., 1986, 378, 8-20.
3. Ausiello C. M., Roda L. G.: Leu-enkephalin binding to cultured human T lymphocytes. Cell Biol. Int. Rep., 1984, 8, 97-106.
4. Bianchi E., Alessandrini C., Guarna M., Tagliamonte A.: Endogenous codeine and morphine are stored in specific brain neurons. Brain Res., 1993, 627, 210-215.
5. Brown S. L., Van Epps D. E.: Suppression of T lymphocyte chemotactic factor production by the opioid peptides β-endorphin and Met-enkephalin. J. Immunol., 1985, 134, 3384-3390.
6. Bryant H. U., Bernton E. W., Kenner J. R., Holaday J. W.: Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology, 1991, 128, 3253-3258.
7. Carr D. J. J., DeCosta B. R., Kim C.-H., Jacobson A. E., Guarcello V., Rice K. C., Blalock J. E.: Opioid receptors on cells of the immune system: evidence for δ-and κ-classes. J. Endocrinol., 1989, 122, 161-168.
8. Carr D. J. J., Kim C.-H., DeCosta B., Jacobson A. E., Rice K. C., Blalock J. E.: Evidence for a δ-class opioid receptor on cells of the immune system. Cell. Immunol., 1988, 116, 44-51.
9. Chadzińska M., Józefowski S., Bigaj J., Płytycz B.: Morphine modulation of thioglycolate-elicited peritoneal inflammation in the goldfish, Carassius auratus L. Arch. Immunol. Ther. Exp., 1997, in press.
10. Chadzińska M., Józkowicz A., Płytycz B., Seljelid R.: Modulatory effects of morphine on an acute peritoneal inflammation: comparative studies. 14th International Congress "The Phagocyte Molecular and Clinical Aspects", Verona, Italy, October 11-14, 1996, J. Leukocyte Biol., 1996, Suppl., 59.
11. Chao C. C., Gekker G., Sheng W. S., Hu S., Tsang M., Peterson P. K.: Priming effect of morphine on the production of tumor necrosis factor-α by microglia: implications in respiratory activity and human immunodeficiency virus-1 expression. J. Pharmacol. Exp. Ther., 1994, 269, 198-203.
12. Chao C. C., Hu S., Molitor T. W., Zhou Y., Murtaugh M. P., Tsang M., Peterson P. K.: Morphine potentiates transforming growth factor-β release from human peripheral blood mononuclear cell cultures. J. Pharmacol. Exp. Ther., 1992, 262, 19-24.
13. Chao C. C., Molitor T. W., Close K., Hu S., Peterson P. K.: Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int. J. Immunopharmacol., 1993, 15, 441-453.
14. Chen Y., Mestek A., Liu J., Hurley J. A., Yu L.: Molecular cloning and functional expression of μ-opioid receptor from rat brain. Mol. Pharmacol., 1993, 44, 8-12.
15. 50) of an enzymatic reaction. Biochem. Pharmacol., 1973, 22, 3099-3108.
16. 3 subtype. J. Pharmacol. Exp. Ther., 1989, 251, 461-468.
17. 3H]Naltrindole: a potent and selective ligand for labeling δ-opioid receptors. Brain Res., 1993, 604, 160-164.
18. Donnerer J., Oka K., Brossi A., Rice K. C., Spector S.: Presence and formation of codeine and morphine in the rat. Proc. Nat. Acad. Sci. USA, 1986, 83, 4566-4567.
19. Emmerson P. J., Liu M.-R., Woods J. H., Medzihradsky F.: Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther., 1994, 271, 1630-1637.
20. Evans C. J., Keith D. E., Morrison H., Magendzo K., Edwards R. H.: Cloning of delta opioid receptor by functional expression. Science, 1992, 258, 1952-1955.
21. Falke N. E., Fischer E. G., Martin R.: Stereospecific opiate binding in living human polymorphonuclear leukocytes. Cell Biol. Int. Rep., 1985, 9, 1041-1047.
22. 3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogenity. J. Pharmacol. Exp. Ther., 1994, 268, 836-846.
23. Fecho K., Dykstra L. A., Lysle D. T.: Evidence for beta-adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther., 1993, 265, 1079-1087.
24. Fecho K., Maslonek K. A., Coussons-Read M. E., Dykstra L. A., Lysle D. T.: Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol., 1994, 152, 5845-5852.
25. Foris G., Medgyesi G. A., Hauck M.: Bidirectional effect of met-enkephalin on macrophage effector functions. Mol. Cell. Biochem., 1986, 69, 127-137.
26. Foster J. S, Moore R. N.: Dynorphin and related peptides enhance tumoricidal activity mediated by murine peritoneal macrophages. J. Leukocyte Biol., 1987, 42, 171-174.
27. Gruca P., Chadzińska M., Lackowska B., Płytycz B.: Analysis of peritoneal and head kidney phagocytosis during thioglycollate-elicited peritoneal inflammation in the goldfish, Carassius auratus. Folia Biol.-Kraków, 1996, 44, 137-142.
28. Gruca P., Józkowicz A., Chadzińska M., Mika J., Józefowski S., Przewłocka B., Przewłocki R., Płytycz B., Seljelid R.: Effects of morphine on acute peritoneal inflammation and bacterial clearance in fish, amphibians and mice. In: Modulators of Immune Responses. The Evolutionary Trail. Eds. Stolen J. S., Fletcher T. C., Bayne C. J., Secombes C. J., Zelikoff J. T., Twerdok L. E., Anderson D. P., SOS Publications, Fair Haven, USA, 1996, vol. 2, 291-300.
29. Hine P. M.: The granulocytes of fish. Fish Shellfish Immunol., 1992, 2, 79-98.
30. House R. V., Thomas P. T., Kozak J. T., Bhargava H. N.: Supression of immune function by non-peptidic opioid receptor antagonists. Neurosci. Lett., 1995, 198, 119-122.
31. Hucklebridge F. H., Hudspith B. N., Lydyard P. M., Brostoff J.: Stimulation of human peripheral lymphocytes by methionine enkephalin and δ-selective opioid analogues. Immunopharmacology, 1990, 19, 87-91.
32. Josefsson J-O., Johansson P.: Naloxone-reversible effect of opioids on pinocytosis in Amoeba proteus. Nature, 1979, 282, 78-80.
33. Kieffer B. L., Befort K., Gaveriaux R. C., Hirth C. G.: The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Nat. Acad. Sci. USA, 1992, 89, 12048-12052.
34. Lopker A., Abood L. G., Hoss W., Lionetti F. J.: Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmacol., 1980, 29, 1361-1365.
35. Lowry O. J., Rosenbrough N. J., Farr N. J., Randall R. J.: Protein measurement with Folin-phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
36. Lysle D. T., Coussons M. E., Watts V. J., Bennett E. H., Dykstra L. A.: Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther., 1993, 265, 1071-1078.
37. Magnan J., Paterson S. J., Tavani A., Kosterlitz H. W.: The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmied. Arch. Pharmacol., 1982, 319, 197-205.
38. Makman M. H.: Morphine receptors in immunocytes and neurons. Adv. Neuroimmunol., 1994, 4, 69-82.
39. Makman M. H, Bilfinger T. V., Stefano G. B.: Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol., 1995, 154, 1323-1330.
40. 3-opiate receptors. Eur. J. Pharmacol., 1995, 273, R5-R6.
41. Marcoli M., Ricevuti G., Mazzone A., Bekkering M., Lecchini S., Frigo G. M.: Opioid-induced modification of granulocyte function. Int. J. Immunopharmacol., 1988, 10, 425-433.
42. Mukherjee S., Baker B. I., Bird D. J., Buckingham J. C.: Hypothalamo-pituitary-interrenal responses to opioid substances in the trout. Gen. Comp. Endocrinol., 1987, 68, 40-48.
43. Nagy J. T., Foris G., Fulop T. Jr., Paragh G., Plotnikoff N. P.: Activation of the lipoxygenase pathway in the methionine enkephalin induced respiratory burst in human polymorphonuclear leukocytes. Life Sci., 1988, 42, 2299-2306.
44. 2 receptor in guinea pig brain. Peptides, 1995, 16, 1083-1095.
45. Nock B., Giordano A. L., Moore B. W., Cicero T. J.: Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain. J. Pharmacol. Exp. Ther., 1993, 264, 349-359.
46. Novick D., Oschshorn M., Ghali V., Croxson T. S., Mercer W. D., Chiorazzi N., Kreek M. J.: Natural killer activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther., 1989, 250, 606-610.
47. Ottaviani E., Petraglia F., Genedani S., Bernardi M., Bertolini A., Cossaritzza A., Monti D., Franceschi C.: Phagocytosis and ACTH-like molecules in invertebrate (Molluscan) and in vertebrate (human) cells. Ann. N.Y. Acad. Sci., 1990, 594, 454-457.
48. Pesce G. O., Cruciani R. A., Munson P. J., Rodbard D.: Computer modelling of subtypes of κ opioid receptors in adrenal medulla. Eur. J. Pharmacol., 1990, 182, 429-439.
49. Peterson P. K., Sharp B., Gekker G., Brummitt C., Keane W. F.: Opioid-mediated suppression of cultured peripheral blood mononuclear cells respiratory burst activity. J. Immunol., 1987, 138, 3907-3912.
50. Peterson P. K., Sharp B., Gekker G., Brummitt C., Keane W. F.: Opioid mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells. J. Clin. Invest., 1987, 80, 824-831.
51. Porini G., Petrillo P., Colombo M., Tavani A.: In vitro binding profile of cyprodime, a reported mu-opioid antagonist. In: New Leads in Opioid Research. Eds. van Ree J. M., Mulder A. H., Wiegant V. M., van Wiemersma Greidamus T. B., Excerpta Medica, Amsterdam, 1990, 225-227.
52. Pruettt S. B., Yun-Cheng H., Fuchs B. A.: Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism. J. Pharmacol. Exp. Ther., 1992, 262, 923-928.
53. Radulović J., Jancović B. D.: Opposing activities of brain receptors in the regulation of humoral and cell-mediated immune responses in the rat. Brain Res., 1994, 661, 189-195.
54. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G. I., Reisine T.: Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol., 1994, 45, 330-334.
55. Rijkers G. T., Frederix-Wolters E. M. H., van Muiswinkel W. B.: The immune system of cyprinid fish. Kinetics and temperature dependence of antibody-producing cells in carp (Cyprinus carpio). Immunology, 1980, 41, 91-97.
56. Sei Y., Yoshimoto K., McIntyre T., Skolnick P., Arora P. K.: Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol., 1991, 146, 194-198.
57. Sharp B. M., Keane W. F., Suh H. J., Gekker G., Tsukayama D., Peterson P. K.: Opioid peptides rapidly stimulate superoxide production by human polymor-phonuclear leukocytes and macrophages. Endocrinology, 1985, 117, 793-795.
58. Sibinga N. E. S., Goldstein A.: Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol., 1988, 6, 219-249.
59. Simantov R., Snowman A. M., Snyder S. H.: Temperature and ionic influences on opiate receptor binding. Mol. Pharmacol., 1976, 12, 977-986.
60. Sonetti D., Ottaviani E., Bianchi F., Rodriguez M., Stefano M. L., Scharrer B., Stefano G. B.: Microglia in invertebrate ganglia. Proc. Nat. Acad. Sci. USA, 1994, 91, 9180-9184.
61. Stefano G. B., Cadet P., Dokun A., Scharrer B.: A neuroimmunoregulatory-like mechanism responding to stress in the marine bivalve Mytilus edulis. Brain Behav. Immun., 1990, 4, 323-329.
62. Stefano G. B., Digenis A., Spector S., Leung M. K., Bilfinger T., Makman M. H., Scharrer B., Abumrad N. N.: Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Nat. Acad. Sci. USA, 1993, 90, 11099-11103.
63. 3 opiate receptor in endothelial cells. J. Biol. Chem., 1995, 270, 30290-30293.
64. Stefano G. B., Leung M. K., Zhao X., Scharrer B.: Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes. Proc. Nat. Acad. Sci. USA, 1989, 86, 626-630.
65. 2]Deltorphin I binding and pharmacological evidence for a special subtype of δ opioid receptor on human and invertebrate immune cells. Proc. Nat. Acad. Sci. USA, 1992, 89, 9316-9320.
66. Stefano G. B., Scharrer B.: Endogenous morphine and related opiates, a new class of chemical messengers. Adv. Neuroimmunol., 1994, 4, 57-67.
67. Takemori A. E., Ho B. Y., Naeseth J. S., Portoghese P. S.: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther., 1988, 246, 255-258.
68. Taub D. D., Eisenstein T. K., Geller E. B., Adler M. W., Rogers T. J.: Immunomodulatory activity of μ-and κ-selective opioid agonists. Proc. Nat. Acad. Sci. USA, 1991, 88, 360-364.
69. Tubaro E., Borelli G., Croce C., Cavallo G., Santiangeli C.: Effect of morphine on resistance to infection. J. Infec. Dis., 1983, 148, 656-666.
70. Tubaro E., Ustic A., Santiangeli C., Zuccaro P., Cavallo G., Pacifici R., Croce C., Borelli G.: Morphine and methadone impact on human phagocytic physiology. Int. J. Immunopharmacol., 1985, 7, 865-874.
71. Wang R., Neumann N. F., Shen Q., Belosevic M.: Establishment and characterization of macrophage cell line from the goldfish. Fish Shellfish Immunol., 1995, 5, 329-346.
72. Wang J.-X., Yamamura H. J., Wang W., Roeske J.: The use of the filtration technique in in vitro radioligand binding assays for membrane bound and solubilized receptors. In: Receptor-Ligand Interactions. A Practical Approach. Ed. Hulme E. C., Oxford University Press Inc., New York, 1993, 213-234.
73. Yasuda K., Raynor K., Kong H., Breder C. D., Takeda J., Reisine T., Bell G. I.: Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Nat. Acad. Sci. USA, 1993, 90, 6736-6740.
74. Zapata A.G., Torroba M., Vicente A., Varas A., Sacedon R., Jimenez E.: The relevance of cell microenvironments for the appearance of lympho-haemopoietic tissues in primitive vertebrates. Histol. Histopathol., 1995, 10, 761-778.